Pictor Labs Launches ClearStain to Enable AI-Driven Tissue Imaging for Sequencing Workflows

Pictor Labs, a digital pathology company, has unveiled ClearStain, an AI-powered imaging and analysis platform that digitizes tissue slides without traditional staining, maintaining RNA and protein quality for downstream sequencing. The system uses computational contrast modeling to replicate histological appearance in silico, allowing for both visual diagnosis and molecular profiling from the same sample.

The launch highlights growing convergence between digital pathology and spatial omics. Pictor’s focus on sequencing-ready preservation could make it key in translational research workflows.

Posted by MedCloudInsider Editors on 11/10/2025